Third Rock raises $516m for early-stage venture deals

Third Rock Ventures has raised $516 million for its third life science venture capital fund with a primary focus on therapeutics startups, bringing the Boston-based firm's total capital raised since 2007 to $1.3 billion - all to finance early-stage companies.